{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:38:35Z","timestamp":1792521515860,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10-11","license":[{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s12012-022-09765-3","type":"journal-article","created":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T11:02:30Z","timestamp":1660993350000},"page":"898-909","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Genistein Alleviates Oxidative Stress and Inflammation in the Hypothalamic Paraventricular Nucleus by Activating the Sirt1\/Nrf2 Pathway in High Salt-Induced Hypertension"],"prefix":"10.1007","volume":"22","author":[{"given":"Li-Gang","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Rui","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ming","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,20]]},"reference":[{"issue":"2019","key":"9765_CR1","first-page":"2106","volume":"40","author":"Tiwana, J., & Yang, E.","year":"2017","unstructured":"Tiwana, J., & Yang, E. (2017). Clinical implications of the 2017 ACC\/AHA hypertension guidelines. European Heart Journal, 40(2019), 2106\u20132109.","journal-title":"European Heart Journal"},{"key":"9765_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills, K. T., Stefanescu, A., & He, J. (2020). The global epidemiology of hypertension. Nature Reviews Nephrology, 16, 223\u2013237.","journal-title":"Nature Reviews Nephrology"},{"key":"9765_CR3","doi-asserted-by":"publisher","first-page":"18014","DOI":"10.1038\/nrdp.2018.14","volume":"4","author":"S Oparil","year":"2018","unstructured":"Oparil, S., Acelajado, M. C., Bakris, G. L., Berlowitz, D. R., Cifkova, R., Dominiczak, A. F., et al. (2018). Hypertension. Nature Reviews Disease Primers, 4, 18014.","journal-title":"Nature Reviews Disease Primers"},{"key":"9765_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-physiol-021317-121134","volume":"80","author":"AJ Rucker","year":"2018","unstructured":"Rucker, A. J., Rudemiller, N. P., & CrowleySalt, S. D. (2018). Hypertension, and immunity. Annual Review of Physiology, 80, 283\u2013307.","journal-title":"Annual Review of Physiology"},{"key":"9765_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.toxlet.2015.10.019","volume":"241","author":"Q Su","year":"2016","unstructured":"Su, Q., Liu, J. J., Cui, W., Shi, X. L., Guo, J., Li, H. B., et al. (2016). Alpha lipoic acid supplementation attenuates reactive oxygen species in hypothalamic paraventricular nucleus and sympathoexcitation in high salt-induced hypertension. Toxicology Letters, 241, 152\u2013158.","journal-title":"Toxicology Letters"},{"key":"9765_CR6","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.neuropharm.2016.11.010","volume":"113","author":"W Sun","year":"2017","unstructured":"Sun, W., Wang, X., Hou, C., Yang, L., Li, H., Guo, J., et al. (2017). Oleuropein improves mitochondrial function to attenuate oxidative stress by activating the Nrf2 pathway in the hypothalamic paraventricular nucleus of spontaneously hypertensive rats. Neuropharmacology, 113, 556\u2013566.","journal-title":"Neuropharmacology"},{"key":"9765_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.taap.2015.02.023","volume":"284","author":"X-J Yu","year":"2015","unstructured":"Yu, X.-J., Zhang, D.-M., Jia, L.-L., Qi, J., Song, X.-A., Tan, H., et al. (2015). Inhibition of NF-\u03baB activity in the hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress. Toxicology and Applied Pharmacology, 284, 315\u2013322.","journal-title":"Toxicology and Applied Pharmacology"},{"key":"9765_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.taap.2014.09.004","volume":"281","author":"XA Song","year":"2014","unstructured":"Song, X. A., Jia, L. L., Cui, W., Zhang, M., Chen, W., Yuan, Z. Y., et al. (2014). Inhibition of TNF-alpha in hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by inhibiting neurohormonal excitation in spontaneously hypertensive rats. Toxicology and Applied Pharmacology, 281, 101\u2013108.","journal-title":"Toxicology and Applied Pharmacology"},{"key":"9765_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.taap.2014.02.002","volume":"276","author":"Q Su","year":"2014","unstructured":"Su, Q., Qin, D. N., Wang, F. X., Ren, J., Li, H. B., Zhang, M., et al. (2014). Inhibition of reactive oxygen species in hypothalamic paraventricular nucleus attenuates the renin-angiotensin system and proinflammatory cytokines in hypertension. Toxicology and Applied Pharmacology, 276, 115\u2013120.","journal-title":"Toxicology and Applied Pharmacology"},{"key":"9765_CR10","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1097\/HJH.0000000000001694","volume":"36","author":"XW Cheng","year":"2018","unstructured":"Cheng, X. W., Narisawa, M., Jin, X., Murohara, T., & Kuzuya, M. (2018). Sirtuin 1 as a potential therapeutic target in pulmonary artery hypertension. Journal of Hypertension, 36, 1032\u20131035.","journal-title":"Journal of Hypertension"},{"key":"9765_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173398","volume":"886","author":"Q Nie","year":"2020","unstructured":"Nie, Q., Zhang, J., He, B., Wang, F., Sun, M., Wang, C., et al. (2020). A novel mechanism of protection against isoproterenol-induced cardiac inflammation via regulation of the SIRT1\/NRF2 signaling pathway with a natural SIRT1 agonist. European Journal of Pharmacology, 886, 173398.","journal-title":"European Journal of Pharmacology"},{"key":"9765_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.etap.2018.04.016","volume":"60","author":"X Sun","year":"2018","unstructured":"Sun, X., Wang, P., Yao, L. P., Wang, W., Gao, Y. M., Zhang, J., et al. (2018). Paeonol alleviated acute alcohol-induced liver injury via SIRT1\/Nrf2\/NF-kappaB signaling pathway. Environmental Toxicology and Pharmacology, 60, 110\u2013117.","journal-title":"Environmental Toxicology and Pharmacology"},{"key":"9765_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.642015","volume":"15","author":"XJ Yu","year":"2021","unstructured":"Yu, X. J., Xin, G. R., Liu, K. L., Liu, X. J., Fu, L. Y., Qi, J., et al. (2021). Paraventricular nucleus infusion of oligomeric proantho cyanidins improves renovascular hypertension. Frontiers in Neuroscience, 15, 642015.","journal-title":"Frontiers in Neuroscience"},{"key":"9765_CR14","first-page":"585","volume":"2017","author":"SM Ahmed","year":"1863","unstructured":"Ahmed, S. M., Luo, L., Namani, A., Wang, X. J., & Tang, X. (1863). Nrf2 signaling pathway: Pivotal roles in inflammation. Biochimica et Biophysica Acta, Molecular Basis of Disease, 2017, 585\u2013597.","journal-title":"Biochimica et Biophysica Acta, Molecular Basis of Disease"},{"key":"9765_CR15","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/molecules25225474","volume":"25","author":"S Saha","year":"2020","unstructured":"Saha, S., Buttari, B., Panieri, E., Profumo, E., & Saso, L. (2020). An overview of Nrf2 signaling pathway and its role in inflammation. Molecules, 25, 5474.","journal-title":"Molecules"},{"key":"9765_CR16","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.3390\/molecules24213892","volume":"24","author":"P Thangavel","year":"2019","unstructured":"Thangavel, P., Puga-Olguin, A., Rodriguez-Landa, J. F., & Zepeda, R. C. (2019). Genistein as potential therapeutic candidate for menopausal symptoms and other related diseases. Molecules, 24, 3892.","journal-title":"Molecules"},{"key":"9765_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.biopha.2015.10.026","volume":"76","author":"AA Ganai","year":"2015","unstructured":"Ganai, A. A., & Farooqi, H. (2015). Bioactivity of genistein: A review of in vitro and in vivo studies. Biomedicine & Pharmacotherapy, 76, 30\u201338.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"9765_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/HYPERTENSIONAHA.112.191445","volume":"60","author":"H Matori","year":"2012","unstructured":"Matori, H., Umar, S., Nadadur, R. D., Sharma, S., Partow-Navid, R., Afkhami, M., et al. (2012). Genistein, a soy phytoestrogen, reverses severe pulmonary hypertension and prevents right heart failure in rats. Hypertension, 60, 425\u2013430.","journal-title":"Hypertension"},{"key":"9765_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11010-015-2483-2","volume":"408","author":"SK Gupta","year":"2015","unstructured":"Gupta, S. K., Dongare, S., Mathur, R., Mohanty, I. R., Srivastava, S., Mathur, S., et al. (2015). Genistein ameliorates cardiac inflammation and oxidative stress in streptozotocin-induced diabetic cardiomyopathy in rats. Molecular and Cellular Biochemistry, 408, 63\u201372.","journal-title":"Molecular and Cellular Biochemistry"},{"key":"9765_CR20","doi-asserted-by":"publisher","first-page":"7028","DOI":"10.1007\/s12035-016-0215-6","volume":"54","author":"KP Devi","year":"2017","unstructured":"Devi, K. P., Shanmuganathan, B., Manayi, A., Nabavi, S. F., & Nabavi, S. M. (2017). Molecular and therapeutic targets of genistein in Alzheimer\u2019s disease. Molecular Neurobiology, 54, 7028\u20137041.","journal-title":"Molecular Neurobiology"},{"key":"9765_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.critrevonc.2017.09.004","volume":"119","author":"V Mukund","year":"2017","unstructured":"Mukund, V., Mukund, D., Sharma, V., Mannarapu, M., & Alam, A. (2017). Genistein: Its role in metabolic diseases and cancer. Critical Reviews in Oncology Hematology, 119, 13\u201322.","journal-title":"Critical Reviews in Oncology Hematology"},{"key":"9765_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/cvr\/cvp160","volume":"83","author":"YM Kang","year":"2009","unstructured":"Kang, Y. M., He, R. L., Yang, L. M., Qin, D. N., Guggilam, A., Elks, C., et al. (2009). Brain tumour necrosis factor-alpha modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure. Cardiovascular Research, 83, 737\u2013746.","journal-title":"Cardiovascular Research"},{"key":"9765_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12012-012-9184-9","volume":"13","author":"J Qi","year":"2012","unstructured":"Qi, J., Zhang, D.-M., Suo, Y.-P., Song, X.-A., Yu, X.-J., Elks, C., et al. (2012). Renin-angiotensin system modulates neurotransmitters in the paraventricular nucleus and contributes to angiotensin II-induced hypertensive response. Cardiovascular Toxicology, 13, 48\u201354.","journal-title":"Cardiovascular Toxicology"},{"key":"9765_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2018.11.024","volume":"58","author":"LP Wang","year":"2019","unstructured":"Wang, L. P., Yuan, D., Zheng, J., Wu, X. C., Wang, J. T., Liu, X., et al. (2019). Chikusetsu saponin IVa attenuates isoprenaline-induced myocardial fibrosis in mice through activation autophagy mediated by AMPK\/mTOR\/ULK1 signaling. Phytomedicine, 58, 152764.","journal-title":"Phytomedicine"},{"key":"9765_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.taap.2014.06.004","volume":"279","author":"HB Li","year":"2014","unstructured":"Li, H. B., Qin, D. N., Ma, L., Miao, Y. W., Zhang, D. M., Lu, Y., et al. (2014). Chronic infusion of lisinopril into hypothalamic paraventricular nucleus modulates cytokines and attenuates oxidative stress in rostral ventrolateral medulla in hypertension. Toxicology and Applied Pharmacology, 279, 141\u2013149.","journal-title":"Toxicology and Applied Pharmacology"},{"key":"9765_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neuropharm.2015.12.023","volume":"103","author":"HJ Sun","year":"2016","unstructured":"Sun, H. J., Chen, D., Han, Y., Zhou, Y. B., Wang, J. J., Chen, Q., et al. (2016). Relaxin in paraventricular nucleus contributes to sympathetic overdrive and hypertension via PI3K-Akt pathway. Neuropharmacology, 103, 247\u2013256.","journal-title":"Neuropharmacology"},{"key":"9765_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12012-015-9338-7","volume":"16","author":"J Qi","year":"2016","unstructured":"Qi, J., Zhao, X. F., Yu, X. J., Yi, Q. Y., Shi, X. L., Tan, H., et al. (2016). Targeting interleukin-1 beta to suppress sympathoexcitation in hypothalamic paraventricular nucleus in Dahl salt-sensitive hypertensive rats. Cardiovascular Toxicology, 16, 298\u2013306.","journal-title":"Cardiovascular Toxicology"},{"key":"9765_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.lfs.2016.06.014","volume":"158","author":"S Incir","year":"2016","unstructured":"Incir, S., Bolayirli, I. M., Inan, O., Aydin, M. S., Bilgin, I. A., Sayan, I., et al. (2016). The effects of genistein supplementation on fructose induced insulin resistance, oxidative stress and inflammation. Life Sciences, 158, 57\u201362.","journal-title":"Life Sciences"},{"key":"9765_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144789","volume":"753","author":"F Gholampour","year":"2020","unstructured":"Gholampour, F., Mohammadi, Z., Karimi, Z., & Owji, S. M. (2020). Protective effect of genistein in a rat model of ischemic acute kidney injury. Gene, 753, 144789.","journal-title":"Gene"},{"key":"9765_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0895-7061(98)00216-7","volume":"12","author":"JM Hodgson","year":"1999","unstructured":"Hodgson, J. M., Puddey, I. P., Beilin, L. J., Mori, T. A., Burke, V., Croft, K. D., & Rogers, P. B. (1999). Effects of isoflavonoids on blood pressure in subjects with high-normal ambulatory blood pressure levels: A randomized controlled trial. American Journal of Hypertension, 12, 47\u201353.","journal-title":"American Journal of Hypertension"},{"key":"9765_CR31","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/eci.12139","volume":"43","author":"C Irace","year":"2013","unstructured":"Irace, C., Marini, H., Bitto, A., Altavilla, D., Polito, F., Adamo, E. B., et al. (2013). Genistein and endothelial function in postmenopausal women with metabolic syndrome. European Journal of Clinical Investigation, 43, 1025\u20131031.","journal-title":"European Journal of Clinical Investigation"},{"key":"9765_CR32","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3389\/fendo.2018.00702","volume":"9","author":"J Xu","year":"2018","unstructured":"Xu, J., Jackson, C. W., Khoury, N., Escobar, I., & Perez-Pinzon, M. A. (2018). Brain SIRT1 mediates metabolic homeostasis and neuroprotection. Frontiers in Endocrinology (Lausanne), 9, 702.","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"key":"9765_CR33","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.freeradbiomed.2019.01.016","volume":"134","author":"CJ Schmidlin","year":"2019","unstructured":"Schmidlin, C. J., Dodson, M. B., Madhavan, L., & Zhang, D. D. (2019). Redox regulation by NRF2 in aging and disease. Free Radical Biology & Medicine, 134, 702\u2013707.","journal-title":"Free Radical Biology & Medicine"},{"key":"9765_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2018.11.034","volume":"59","author":"L Li","year":"2019","unstructured":"Li, L., Luo, W., Qian, Y., Zhu, W., Qian, J., Li, J., et al. (2019). Luteolin protects against diabetic cardiomyopathy by inhibiting NF-kappaB-mediated inflammation and activating the Nrf2-mediated antioxidant responses. Phytomedicine, 59, 152774.","journal-title":"Phytomedicine"},{"key":"9765_CR35","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/ki.2012.439","volume":"83","author":"S Ruiz","year":"2013","unstructured":"Ruiz, S., Pergola, P. E., Zager, R. A., & Vaziri, N. D. (2013). Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney International, 83, 1029\u20131041.","journal-title":"Kidney International"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-022-09765-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-022-09765-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-022-09765-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T12:20:27Z","timestamp":1666786827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-022-09765-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,20]]},"references-count":35,"journal-issue":{"issue":"10-11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["9765"],"URL":"https:\/\/doi.org\/10.1007\/s12012-022-09765-3","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,20]]},"assertion":[{"value":"18 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}